Stryker Corp. (SYK)
NYSE
Closed
Oct 7, 2026
Day's Range
274.4552 wk Range
267.00Overview - SYK - Stryker Corp.
Key Statistics
Valuation
Enterprise Value
117.60B
P/E (Trailing)
‪28.31‬
P/E (Forward)
‪16.32‬
PEG Ratio
‪0.65‬
Price / Sales (TTM)
‪4.05‬
Price / Book
‪4.36‬
EV / EBITDA
‪15.94‬
Profitability
Gross Margin
‪68.26%‬
Profit Margin
‪14.43%‬
Operating Margin
‪27.01%‬
Return on Assets
‪8.16%‬
Return on Equity
‪16.50%‬
Ownership
Shares Outstanding
383.57M
Float
348.14M
Short % of Shares Outstanding
‪2.09%‬
Held by Insiders
‪5.36%‬
Held by Institutions
‪82.79%‬
Price stats
Beta
‪0.76‬
50-Day Avg
‪312.81‬
200-Day Avg
‪331.01‬
Dividends
Payout Ratio
‪36.06%‬
Frequency
Quarterly
Analyst Consensus
28 analysts
Average price target
‪$ 382.72‬Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SYK - Stryker Corp.
Peers - SYK - Stryker Corp.
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
Profile Summary - SYK - Stryker Corp.
About
Stryker Corp. is a medical technology company focused on products and services that support patient care and healthcare delivery. The company operates across MedSurg, Neurotechnology, and Orthopaedics, supplying hospitals, surgeons, and other healthcare providers with surgical equipment, endoscopic and communications…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
